Cyclerion Therapeutics (CYCN) Asset Writedowns and Impairment (2023)

Cyclerion Therapeutics' Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $3.3 million for Q3 2023.

• In Q3 2023, Asset Writedowns and Impairment changed N/A year-over-year to $3.3 million; the TTM figure through Dec 2024 stood at $3.3 million (changed 0.0% YoY), while the FY2023 annual figure was $3.3 million, changed N/A from the prior year.
• Asset Writedowns and Impairment for Q3 2023 stood at $3.3 million.
• The five-year high for Asset Writedowns and Impairment was $3.3 million in Q3 2023, with the low at $3.3 million in Q3 2023.